ResearcherSeoul National UniversityActive in the last 2 years
Yeon Bi Han
Matched on ORCID iD 0000-0002-3657-5012; OpenAlex author ID A5062716517. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2024: 1 paper · 2025: 1 paper
Papers 2
- Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cancer. Co-author DOI 10.1186/s12967-025-06599-9↗
- Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study. First author DOI 10.1016/j.pan.2024.03.013↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoo‐Seok Yoon · 2 shared papers, 2024–2025 · strength 0.42
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: … DOI 10.1016/j.pan.2024.03.013↗
- Ho‐Seong Han · 2 shared papers, 2024–2025 · strength 0.42
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: … DOI 10.1016/j.pan.2024.03.013↗
- Soomin Ahn · 1 shared paper, 2025 · strength 0.22
- Kwangrok Jung · 1 shared paper, 2025 · strength 0.22
- Jin‐Hyeok Hwang · 1 shared paper, 2025 · strength 0.22
- Jaihwan Kim · 1 shared paper, 2025 · strength 0.22
- Yeshong Park · 1 shared paper, 2024 · strength 0.20
- Haeryoung Kim · 1 shared paper, 2024 · strength 0.20
- MeeYoung Kang · 1 shared paper, 2024 · strength 0.20
- Jinju Kim · 1 shared paper, 2024 · strength 0.20
- Boram Lee · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.